Skip to content
MMR Sign In Subscribe
Pharmacy — Supplier News

Camber launches theophylline extended-Release tablets

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of theophylline extended-release tablets to its current portfolio.

,   and  Bill Schiffner
1 min read

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of theophylline extended-release tablets to its current portfolio.

Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.

Theophylline extended-release tablets are available in 300 mg and 450 mg strengths, both in 100 count bottles.  

To find out more about theophylline extended-release tablets, visit  https://www.camberpharma.com/theophylline-er

Related

Latest

P&G to buy Thorne
Supplier News

P&G to buy Thorne

For P&G, the acquisition introduces a premium supplement and wellness platform, capitalizing on growing consumer interest in preventive health and personalized wellness.

,   and  CDR
Ahold Delhaize reiterates outlook after resilient Q2
Retail News

Ahold Delhaize reiterates outlook after resilient Q2

In the United States, net sales increased 1.4% at constant exchange rates, while comparable sales excluding gasoline rose 0.8%. Results were pressured by lower egg prices, reduced SNAP benefits, and pharmacy pricing changes related to the Inflation Reduction Act.

,   and  CDR